Ignite Creation Date:
2025-12-24 @ 6:40 PM
Ignite Modification Date:
2025-12-29 @ 11:46 PM
Study NCT ID:
NCT04990557
Status:
UNKNOWN
Last Update Posted:
2021-08-16
First Post:
2021-08-01
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
CRISPR/Cas9-modified Human T Cell ( PD-1and ACE2 Knockout Engineered T Cells ) for Inducing Long-term Immunity in COVID-19 Patients
Sponsor:
Mahmoud Ramadan mohamed Elkazzaz
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2021-08
Start Date Type:
ESTIMATED
Primary Completion Date:
2022-11
Primary Completion Date Type:
ESTIMATED
Completion Date:
2022-11
Completion Date Type:
ESTIMATED
First Submit Date:
2021-08-01
First Submit QC Date:
None
Study First Post Date:
2021-08-04
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2021-08-13
Last Update Post Date:
2021-08-16
Last Update Post Date Type:
ACTUAL